Vaxart Inc

NASDAQ: VXRT    
Share price (4/24/24): $0.71    
Market cap (4/24/24): $126 million
Search in Documents
Key Exhibits
External Links

Articles of Incorporation Filter

EX-3.1
from 8-K ~20 pages Amended and Restated Bylaws of Vaxart, Inc
12/34/56
EX-3.3
from 10-Q 2 pages Certificate of Amendment Certificate of Amendment of Restated Certificate of Incorporation of Vaxart, Inc
12/34/56
EX-3.1
from 8-K 11 pages Amended and Restated Bylaws of Vaxart, Inc
12/34/56
EX-3.1
from 8-K 2 pages Certificate of Amendment of Restated Certificate of Incorporation of Vaxart, Inc
12/34/56
EX-3.1
from 8-K 2 pages Certificate of Amendment of Restated Certificate of Incorporation of Vaxart, Inc
12/34/56
EX-3
from SC 13D 7 pages Form of Company Support Agreement
12/34/56
EX-3.2
from 8-K 3 pages Certificate of Amendment of Restated Certificate of Incorporation of Vaxart, Inc
12/34/56
EX-3.1
from 8-K 2 pages Certificate of Amendment of the Restated Certificate of Incorporation of Aviragen Therapeutics, Inc
12/34/56
EX-3.2
from 10-K 17 pages Restated By-Laws of Aviragen Therapeutics, Inc
12/34/56
EX-3.1
from 10-K 25 pages Restated Certificate of Incorporation of Aviragen Therapeutics, Inc
12/34/56
EX-3.2
from 8-K 1 page Certificate of Amendment of the Bylaws (As Amended) of Aviragen Therapeutics, Inc
12/34/56
EX-3.1
from 8-K 3 pages Certificate of Amendment of the Certificate of Incorporation of Biota Pharmaceuticals, Inc
12/34/56
EX-3.1
from 8-K 13 pages By-Laws of Biota Pharmaceuticals, Inc
12/34/56
EX-3.2
from 10-Q 13 pages By-Laws of Biota Pharmaceuticals, Inc
12/34/56
EX-3.1
from 10-Q 6 pages Composite Certificate of Incorporation of Biota Pharmaceuticals, Inc
12/34/56
EX-3.2
from 8-K 1 page Certificate of Amendment of Restated Certificate of Incorporation of NABI Biopharmaceuticals
12/34/56
EX-3.1
from 8-K 1 page Certificate of Amendment of Restated Certificate of Incorporation of NABI Biopharmaceuticals
12/34/56
EX-3.1
from 8-K 1 page Certificate of Amendment of Restated Certificate of Incorporation of NABI Biopharmaceuticals
12/34/56
EX-3.1
from 8-K 19 pages By-Laws of NABI Biopharmaceuticals
12/34/56
EX-3.1
from DEFA14A 19 pages By-Laws of NABI Biopharmaceuticals
12/34/56